Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aspen Neuroscience, a US-based cell therapy developer targeting Parkinson’s disease on the back of Scripps Research Institute work, has formally debuted with $6.5m in seed cash co-led by Domain Associates and Axon Ventures. Alexandria Venture Investments – the strategic investment division of life sciences real estate investment trust Alexandria Real Estate Equities – took part in the round, as did Arch Venture Partners, OrbiMed and Section 32. The company’s approach focuses on pluripotent stem cells which are extracted from the…
